小脑脑桥角肿瘤治疗后发生交通性脑积水
回顾性单中心队列研究纳入405例(286例神经鞘瘤、119例脑膜瘤),分析症状性交通性脑积水累积发生率。神经鞘瘤风险显著高于脑膜瘤(HR 4.70,95%CI 1.78-12.4,P=0.002);仅接受立体定向放射外科治疗的神经鞘瘤患者发生率10.6% vs 脑膜瘤1.4%(P=0.037)。Koos III级前庭神经鞘瘤患者手术切除较SRS更有利于预防脑积水(OR 0.089,95%CI 0.011-0.743,P=0.025)。
要点
- 神经鞘瘤发生症状性交通性脑积水的风险显著高于脑膜瘤(HR 4.70)。
- 仅接受SRS的神经鞘瘤患者脑积水发生率10.6%,脑膜瘤为1.4%。
- Koos III级前庭神经鞘瘤患者手术切除较SRS降低脑积水风险(OR 0.089)。
核心结论
- 症状性交通性脑积水在神经鞘瘤中比脑膜瘤更常见。
- 在特定前庭神经鞘瘤亚组中,以肿瘤切除作为初始治疗可降低脑积水风险。
研究设计与样本
- 本研究为回顾性单中心队列研究,共回顾405例,包括286例神经鞘瘤和119例脑膜瘤。
- 评估神经鞘瘤和脑膜瘤患者症状性交通性脑积水的累积发生率。
- 采用多变量Cox模型评估危险因素的风险比及不同治疗亚组的比值比。
主要发现
- 神经鞘瘤的脑积水风险显著高于脑膜瘤(风险比4.70,95%置信区间1.78-12.4,P=0.002)。
- 接受SRS而未行肿瘤切除的神经鞘瘤患者脑积水发生率显著高于脑膜瘤患者:10.6% vs 1.4%(P=0.037)。
- Koos III级前庭神经鞘瘤患者接受肿瘤切除较接受SRS在预防脑积水方面获益更大(比值比0.089,95%置信区间0.011-0.743,P=0.025)。
- 研究识别出仅接受SRS治疗时易增加脑积水风险的特定亚组。
关键数值与推荐
- 神经鞘瘤 vs 脑膜瘤的脑积水风险:HR 4.70(95%CI 1.78-12.4,P=0.002)。
- 仅SRS的神经鞘瘤 vs 脑膜瘤脑积水发生率:10.6% vs 1.4%(P=0.037)。
- Koos III级前庭神经鞘瘤手术切除 vs SRS预防脑积水的OR:0.089(95%CI 0.011-0.743,P=0.025)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本研究为回顾性单中心队列研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to clarify the risk of communicating hydrocephalus in cerebellopontine angle tumors, focusing on distinct tumor types and treatment modalities, i.e., tumor resection and stereotactic radiosurgery (SRS). METHODS: This study was a retrospective single-center cohort study. The cumulative incidences of symptomatic communicating hydrocephalus in schwannoma and meningioma patients were evaluated. A multivariate Cox model was used to assess the hazard ratios for the risk factors and odds ratios of distinct treatment subgroups. RESULTS: A total of 405 cases, including 286 schwannomas and 119 meningiomas, were retrospectively reviewed. The risk of hydrocephalus was significantly higher in schwannomas than that in meningiomas (hazard ratio, 4.70 [95% confidence interval, 1.78-12.4, P = 0.002]). Patients with schwannomas who received SRS without tumor resection showed a significantly higher incidence than meningioma cases: 10.6% versus 1.4% (P = 0.037). We identified specific subgroups that were prone to increase the risk of hydrocephalus when treated with SRS alone. The result showed that patients with vestibular schwannoma of Koos grade III had a greater benefit from tumor resection than from SRS in preventing hydrocephalus (odds ratio, 0.089 [95% confidence interval, 0.011-0.743, P = 0.025]). CONCLUSIONS: Symptomatic communicating hydrocephalus is more frequent in schwannoma than that in meningiomas. Primary treatment with tumor resection lowers the risk of hydrocephalus in specific subgroups of vestibular schwannoma.
引用
- Kim J, Woo B, Ji S, et al. Communicating Hydrocephalus Following Treatment of Cerebellopontine Angle Tumors. World Neurosurg. 2022. PMID: 35760327. doi:10.1016/j.wneu.2022.06.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。